Learn how other UK businesses have used external finance to reach their ambition
Here’s just some of the tens of thousands of smaller businesses funded through our partners, with the support of British Business Bank’s programmes.
Displaying 1 - 6 of 6 results
Showing 1 - 6 of 6 results
OrganOx
OrganOx is at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation. OrganOx accessed venture capital via the Enterprise Capital Funds (ECF) programme, which it used to fund the clinical studies to secure market approval for its product, a complex class III medical device.
Quell Therapeutics
Founded in 2019, Quell Therapeutics is a leader in engineered T-regulatory (Treg) cell therapies for medical conditions driven by abnormal immune responses.
Cambridge Innovation Capital
Launched in 2013, Cambridge Innovation Capital (CIC) invests in deep-tech and life sciences businesses that have a connection with the Cambridge ecosystem.
Magnitude Biosciences
Magnitude Biosciences, a specialist contract research organisation (CRO) in County Durham offering in vivo discovery of treatments for age-related conditions and other diseases using C. elegans, secured over £706,000 in combined funding to scale up its high-throughput screening (HTS) platform
Ori Biotech
Ori Biotech’s mission is to eliminate barriers to patient access of cell and gene therapies (CGTs) through the use of innovation and by rethinking how those therapies are manufactured.
Elasmogen
Part of a cluster of biotech companies in Aberdeen, Elasmogen uses its bespoke technology platform to isolate innovative drugs for treating cancers and auto-immune diseases.